282 related articles for article (PubMed ID: 26808711)
1. Long-Term Mortality and Major Adverse Cardiovascular Events in Sepsis Survivors. A Nationwide Population-based Study.
Ou SM; Chu H; Chao PW; Lee YJ; Kuo SC; Chen TJ; Tseng CM; Shih CJ; Chen YT
Am J Respir Crit Care Med; 2016 Jul; 194(2):209-17. PubMed ID: 26808711
[TBL] [Abstract][Full Text] [Related]
2. Long-Term Risk of Cardiovascular Events in Patients With Chronic Kidney Disease Who Have Survived Sepsis: A Nationwide Cohort Study.
Shih CJ; Chao PW; Ou SM; Chen YT
J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28188252
[TBL] [Abstract][Full Text] [Related]
3. Long-term clinical outcome of major adverse cardiac events in survivors of infective endocarditis: a nationwide population-based study.
Shih CJ; Chu H; Chao PW; Lee YJ; Kuo SC; Li SY; Tarng DC; Yang CY; Yang WC; Ou SM; Chen YT
Circulation; 2014 Nov; 130(19):1684-91. PubMed ID: 25223982
[TBL] [Abstract][Full Text] [Related]
4. Impact of post-sepsis cardiovascular complications on mortality in sepsis survivors: a population-based study.
Wu MH; Tsou PY; Wang YH; Lee MG; Chao CCT; Lee WC; Lee SH; Hu JR; Wu JY; Chang SS; Lee CC
Crit Care; 2019 Sep; 23(1):293. PubMed ID: 31477181
[TBL] [Abstract][Full Text] [Related]
5. The impact of chronic hepatitis B infection on major adverse cardiovascular events and all-cause mortality in patients with diabetes: a nationwide population-based study from Taiwan.
Kuo CS; Chen YT; Hsu CY; Chang CC; Chou RH; Li SY; Kuo SC; Huang PH; Chen JW; Lin SJ
BMJ Open; 2017 Aug; 7(8):e016179. PubMed ID: 28827251
[TBL] [Abstract][Full Text] [Related]
6. Prevalent diabetes and long-term cardiovascular outcomes in adult sepsis survivors: a population-based cohort study.
Angriman F; Lawler PR; Shah BR; Martin CM; Scales DC;
Crit Care; 2023 Jul; 27(1):302. PubMed ID: 37525272
[TBL] [Abstract][Full Text] [Related]
7. Risk Factors for Major Cardiovascular Events in Adult Sepsis Survivors: A Population-Based Cohort Study.
Angriman F; Rosella LC; Lawler PR; Ko DT; Martin CM; Wunsch H; Scales DC;
Crit Care Med; 2023 Apr; 51(4):471-483. PubMed ID: 36790198
[TBL] [Abstract][Full Text] [Related]
8. An Analysis of Long-Term Ischemic Stroke Risk in Survivors of Septicemia.
Cheng CA; Cheng CG; Lee JT; Lin HC; Cheng CC; Chiu HW
J Stroke Cerebrovasc Dis; 2017 Dec; 26(12):2893-2900. PubMed ID: 28802520
[TBL] [Abstract][Full Text] [Related]
9. Hyperlactatemia is associated with increased risks of long-term mortality and major adverse cardiovascular events in sepsis survivors.
Ou SY; Lee YJ; Chou YM; Sun GC; Chia YY
Infect Dis (Lond); 2023 Aug; 55(8):576-584. PubMed ID: 37334716
[TBL] [Abstract][Full Text] [Related]
10. Association between hyperglycaemic crisis and long-term major adverse cardiovascular events: a nationwide population-based, propensity score-matched, cohort study.
Chang LH; Lin LY; Tsai MT; How CK; Chiang JH; Hsieh VC; Hu SY; Hsieh MS
BMJ Open; 2016 Aug; 6(8):e012233. PubMed ID: 27554106
[TBL] [Abstract][Full Text] [Related]
11. Effects of DPP-4 inhibitors on cardiovascular outcomes in patients with type 2 diabetes and end-stage renal disease.
Chan SY; Ou SM; Chen YT; Shih CJ
Int J Cardiol; 2016 Sep; 218():170-175. PubMed ID: 27236110
[TBL] [Abstract][Full Text] [Related]
12. Sepsis hospitalization and risk of subsequent cardiovascular events in adults: a population-based matched cohort study.
Angriman F; Rosella LC; Lawler PR; Ko DT; Wunsch H; Scales DC
Intensive Care Med; 2022 Apr; 48(4):448-457. PubMed ID: 35142896
[TBL] [Abstract][Full Text] [Related]
13. Risks of Death and Stroke in Patients Undergoing Hemodialysis With New-Onset Atrial Fibrillation: A Competing-Risk Analysis of a Nationwide Cohort.
Shih CJ; Ou SM; Chao PW; Kuo SC; Lee YJ; Yang CY; Tarng DC; Lin CC; Huang PH; Li SY; Chen YT
Circulation; 2016 Jan; 133(3):265-72. PubMed ID: 26680239
[TBL] [Abstract][Full Text] [Related]
14. Effects of Renin-Angiotensin-Aldosterone System Inhibitors on Long-Term Major Adverse Cardiovascular Events in Sepsis Survivors.
Ou SY; Lee YJ; Lo Y; Chen CH; Huang YC; Kuo YT; Chia YY
J Am Heart Assoc; 2021 Dec; 10(23):e022870. PubMed ID: 34845916
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular Outcomes of Dipeptidyl Peptidase-4 Inhibitors in Elderly Patients With Type 2 Diabetes: A Nationwide Study.
Shih CJ; Chen HT; Kuo SC; Ou SM; Chen YT
J Am Med Dir Assoc; 2016 Jan; 17(1):59-64. PubMed ID: 26612484
[TBL] [Abstract][Full Text] [Related]
16. Susceptible period for cardiovascular complications in patients recovering from sepsis.
Lai CC; Lee MG; Lee WC; Chao CC; Hsu TC; Lee SH; Lee CC;
CMAJ; 2018 Sep; 190(36):E1062-E1069. PubMed ID: 30201613
[TBL] [Abstract][Full Text] [Related]
17. Major adverse cardiovascular events and mortality in systemic lupus erythematosus patients after successful delivery: a population-based study.
Wu LS; Tang CH; Lin YS; Lin CP; Hung ST; Hwa HL; Luo SF; Chu PH
Am J Med Sci; 2014 Jan; 347(1):42-9. PubMed ID: 23255242
[TBL] [Abstract][Full Text] [Related]
18. Antecedent hypertension and the effect of captopril on the risk of adverse cardiovascular outcomes after acute myocardial infarction with left ventricular systolic dysfunction: Insights from the Survival and Ventricular Enlargement Trial.
Kenchaiah S; Davis BR; Braunwald E; Rouleau JL; Dagenais GR; Sussex B; Steingart RM; Brown EJ; Lamas GA; Gordon D; Bernstein V; Pfeffer MA;
Am Heart J; 2004 Aug; 148(2):356-64. PubMed ID: 15309009
[TBL] [Abstract][Full Text] [Related]
19. Long-term risk of cardiovascular disease in 10-year survivors of breast cancer.
Hooning MJ; Botma A; Aleman BM; Baaijens MH; Bartelink H; Klijn JG; Taylor CW; van Leeuwen FE
J Natl Cancer Inst; 2007 Mar; 99(5):365-75. PubMed ID: 17341728
[TBL] [Abstract][Full Text] [Related]
20. Risk of cardiovascular events in survivors of severe sepsis.
Yende S; Linde-Zwirble W; Mayr F; Weissfeld LA; Reis S; Angus DC
Am J Respir Crit Care Med; 2014 May; 189(9):1065-74. PubMed ID: 24456535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
